Required Time-Sensitive Notification. Under an IND or IDE, the sponsor must provide FDA safety reports of serious adverse events. Under these Clinical Terms of Award, the Contractor must submit copies to the responsible Contracting Officer’s representative (COR) as follows:
Appears in 2 contracts
Sources: Contract (MediWound Ltd.), Contract (Paratek Pharmaceuticals, Inc.)